Lumida
/ENSG
⌘K
Ensign Group Inc

Ensign Group Inc

ENSG
$173.98USD+0.69%+1.19 today

MARKET CAP

10.1B

P/E (TTM)

28.3x

FWD P/E

DAY RANGE

$172 – $176

52W RANGE

$142
$218

AI Summary

Stalk
Buy NowMedium

ENSG is forming an early Stage 1 base after a sustained decline, with price now stabilizing above the repaired 9 EMA and 21 EMA and volume contracting post-washout. A high-volume “F” candle on the mid-June low signals initial accumulation, and repeated tests of the rising EMA zone offer favorable pullback entries into the uptrending short-term regime.

  • Q2 2026 revenue $1.4B (+17.3% YoY), adjusted EPS $1.92 (+22.5%)
  • Raised FY26 revenue guidance to $5.87–$5.92B; EPS to $7.75–$7.85
  • Ongoing securities investigations and short-seller claims increase volatility
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

The Ensign Group, Inc. (NASDAQ: ENSG) is a prominent player in the post-acute healthcare sector, specializing in skilled nursing facilities and rehabilitative care services. The company has a reputation for transforming underperforming facilities into high-quality care centers by leveraging strong operational leadership and a culture of accountability. Ensign's integrated clinical care models offer a competitive advantage in delivering superior outcomes. The ongoing demographic trends favoring senior care services position the organization favorably in a growing market, driving its strategic initiatives and acquisitions.

Bull says

  • Q2 2026 revenue $1.4B (+17.3% YoY), adjusted EPS $1.92 (+22.5%)
  • Raised FY26 revenue guidance to $5.87–$5.92B; EPS to $7.75–$7.85
  • Integrated 20 new facilities in Q2; occupancy at 84%, boosting scale
  • Liquidity of $592M under credit lines supports M&A and operations
  • High-growth profile with positive analyst revisions and low price volatility
  • Demographic tailwind: U.S. senior population (80+) to rise >50% by 2035

Bear says

  • Ongoing securities investigations and short-seller claims increase volatility
  • Negative earnings yield and near-zero 0.0043% dividend yield deter income investors
  • Low institutional interest: negative 13F ownership may limit share support
  • Integration challenges: many new facilities underperform average occupancies
  • Rising labor costs risk compressing operating margins amid inflation
  • Reimbursement and policy shifts could disrupt Medicaid/Medicare revenue streams

Investment themes with ENSG

Health Care Providers -0.37%

UNH · CVS · HCA
Demographics: Elderly Care -0.50%

Services and products for aging population

UCB.BR · JNJ · AZN

Earnings Call · Q2 2025 · Mgmt. Guidance

Updated 08-01-2026bullish

Transcript signals

Bull points

  • is a scalable approach to growth and one that we can handle.
  • GAAP diluted earnings per share was $1.44, an increase of 18%.
  • Adjusted diluted earnings per share was $1.59, an increase of 20.5%.

Bear points

  • I suspect that, you know, with more finite budgets, that there will be some movement in terms of how they shift dollars around, but there is not a state we operate in where legislators have the sentiment that they feel like skilled nursing is overfunded. In every state we operate in, there's always a push to how do we find more money to get you better funded, not the opposite.
Read full transcript analysis ›